Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.

Schifitto G, Zhang J, Evans SR, Sacktor N, Simpson D, Millar LL, Hung VL, Miller EN, Smith E, Ellis RJ, Valcour V, Singer E, Marra CM, Kolson D, Weihe J, Remmel R, Katzenstein D, Clifford DB; ACTG A5090 Team.

Neurology. 2007 Sep 25;69(13):1314-21. Epub 2007 Jul 25.

PMID:
17652642
2.

A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment.

Clifford DB, McArthur JC, Schifitto G, Kieburtz K, McDermott MP, Letendre S, Cohen BA, Marder K, Ellis RJ, Marra CM; Neurologic AIDS Research Consortium.

Neurology. 2002 Nov 26;59(10):1568-73.

PMID:
12451199
3.

Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090.

Evans SR, Yeh TM, Sacktor N, Clifford DB, Simpson D, Miller EN, Ellis RJ, Valcour V, Marra CM, Millar L, Schifitto G; AIDS Clinical Trials Group and the Neurologic AIDS Research Consortium.

HIV Clin Trials. 2007 Nov-Dec;8(6):437-46.

PMID:
18042509
5.

Selegiline and oxidative stress in HIV-associated cognitive impairment.

Schifitto G, Yiannoutsos CT, Ernst T, Navia BA, Nath A, Sacktor N, Anderson C, Marra CM, Clifford DB; ACTG 5114 Team.

Neurology. 2009 Dec 8;73(23):1975-81. doi: 10.1212/WNL.0b013e3181c51a48. Epub 2009 Nov 4.

7.

Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.

Schifitto G, Navia BA, Yiannoutsos CT, Marra CM, Chang L, Ernst T, Jarvik JG, Miller EN, Singer EJ, Ellis RJ, Kolson DL, Simpson D, Nath A, Berger J, Shriver SL, Millar LL, Colquhoun D, Lenkinski R, Gonzalez RG, Lipton SA; Adult AIDS Clinical Trial Group (ACTG) 301; 700 Teams; HIV MRS Consortium.

AIDS. 2007 Sep 12;21(14):1877-86.

PMID:
17721095
8.

Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment.

Heseltine PN, Goodkin K, Atkinson JH, Vitiello B, Rochon J, Heaton RK, Eaton EM, Wilkie FL, Sobel E, Brown SJ, Feaster D, Schneider L, Goldschmidts WL, Stover ES.

Arch Neurol. 1998 Jan;55(1):41-51.

PMID:
9443710
9.

A phase I/II trial of nimodipine for HIV-related neurologic complications.

Navia BA, Dafni U, Simpson D, Tucker T, Singer E, McArthur JC, Yiannoutsos C, Zaborski L, Lipton SA.

Neurology. 1998 Jul;51(1):221-8.

PMID:
9674806
10.

Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study.

Sacktor N, Schifitto G, McDermott MP, Marder K, McArthur JC, Kieburtz K.

Neurology. 2000 Jan 11;54(1):233-5.

PMID:
10636157
12.

Lost in translation: again, another failed neuroprotection trial.

Brew BJ.

Neurology. 2007 Sep 25;69(13):1308-9. No abstract available.

PMID:
17893290
13.

Symptoms of sexual dysfunction in patients treated for major depressive disorder: a meta-analysis comparing selegiline transdermal system and placebo using a patient-rated scale.

Clayton AH, Campbell BJ, Favit A, Yang Y, Moonsammy G, Piontek CM, Amsterdam JD.

J Clin Psychiatry. 2007 Dec;68(12):1860-6.

PMID:
18162016
14.

The HIV Dementia Scale: predictive power in mild dementia and HAART.

Bottiggi KA, Chang JJ, Schmitt FA, Avison MJ, Mootoor Y, Nath A, Berger JR.

J Neurol Sci. 2007 Sep 15;260(1-2):11-5. Epub 2007 May 4.

PMID:
17482212
15.

Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group.

Sidtis JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, Richman DD, Hirsch MS, Schaerf FW, Fischl MA, Kieburtz K, et al.

Ann Neurol. 1993 Apr;33(4):343-9.

PMID:
8489204
16.

Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium.

Schifitto G, Sacktor N, Marder K, McDermott MP, McArthur JC, Kieburtz K, Small S, Epstein LG.

Neurology. 1999 Jul 22;53(2):391-6.

PMID:
10430432
17.

Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial.

Sacktor N, Miyahara S, Deng L, Evans S, Schifitto G, Cohen BA, Paul R, Robertson K, Jarocki B, Scarsi K, Coombs RW, Zink MC, Nath A, Smith E, Ellis RJ, Singer E, Weihe J, McCarthy S, Hosey L, Clifford DB; ACTG A5235 team.

Neurology. 2011 Sep 20;77(12):1135-42. doi: 10.1212/WNL.0b013e31822f0412. Epub 2011 Sep 7.

18.

DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.

Diener HC, Schneider D, Lampl Y, Bornstein NM, Kozak A, Rosenberg G.

Stroke. 2008 Jun;39(6):1774-8. doi: 10.1161/STROKEAHA.107.506378. Epub 2008 Apr 10.

19.

Selegiline in the treatment of mild to moderate Alzheimer-type dementia.

Monteverde A, Gnemmi P, Rossi F, Monteverde A, Finali GC.

Clin Ther. 1990 Jul-Aug;12(4):315-22.

PMID:
2121360
20.

Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment.

Nakasujja N, Miyahara S, Evans S, Lee A, Musisi S, Katabira E, Robertson K, Ronald A, Clifford DB, Sacktor N.

Neurology. 2013 Jan 8;80(2):196-202. doi: 10.1212/WNL.0b013e31827b9121. Epub 2012 Dec 26.

Items per page

Supplemental Content

Write to the Help Desk